Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pfizer and other ETFs, options, and stocks.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
88,000
Employees88,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
88,000
Employees88,000

PFE Key Statistics

Market cap
174.39B
Market cap174.39B
Price-Earnings ratio
-506.92
Price-Earnings ratio-506.92
Dividend yield
5.50%
Dividend yield5.50%
Average volume
35.97M
Average volume35.97M
High today
$30.88
High today$30.88
Low today
$29.84
Low today$29.84
Open price
$30.15
Open price$30.15
Volume
35.66M
Volume35.66M
52 Week high
$37.19
52 Week high$37.19
52 Week low
$25.20
52 Week low$25.20

PFE News

Benzinga 15h
Freeport-McMoRan, Pfizer, Danaher And An Industrial Stock: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management named Freeport-McMoRan Inc. FCX as her final trade. On July 23, Freep...

Freeport-McMoRan, Pfizer, Danaher And An Industrial Stock: CNBC's 'Final Trades'
Seeking Alpha 16h
Pfizer, Merck bladder cancer therapy endorsed for approval in EU

Merck (NYSE:MRK) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed its blockbuster anti-PD-1 therapy...

Pfizer, Merck bladder cancer therapy endorsed for approval in EU
Benzinga 1d
How To Earn $100 Per Month From Pfizer Stock

How To Earn $100 Per Month From Pfizer Stock Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Pfizer (NYSE...

How To Earn $100 Per Month From Pfizer Stock

Analyst ratings

63%

of 24 ratings
Buy
37.5%
Hold
62.5%
Sell
0%

More PFE News

Benzinga 1d
What's Going On With Pfizer Stock Thursday?

Pfizer, Inc. PFE shares are slightly higher on Thursday after the European Commission approved Pfizer’s DURVEQTIX. Pfizer announced Thursday that the European...

What's Going On With Pfizer Stock Thursday?
TipRanks 2d
New Win for Pfizer Provides Slight Boost

Pfizer (PFE) has been working frantically on new potential winning cures since the COVID-19 vaccine’s impact started to dwindle. And it may be one step closer t...

Investor's Business Daily 2d
Is Pfizer Stock A Buy After Breaking Out On Obesity Treatment Fervor?

Pfizer (PFE) stock briefly broke out in mid-July, helped by the company's decision to move forward with a daily oral treatment for obesity. The company will co...

Is Pfizer Stock A Buy After Breaking Out On Obesity Treatment Fervor?
Benzinga 3d
Sangamo Stock Spikes As Pfizer Partnership Meets Goal In Late-Stage Study

Sangamo Therapeutics Inc SGMO, which developed a treatment in collaboration with Pfizer Inc PFE, received a boost to its stock price after struggling with liqui...

Sangamo Stock Spikes As Pfizer Partnership Meets Goal In Late-Stage Study
Benzinga 3d
Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial

Tuesday, GSK Plc GSK / Pfizer Inc PFE-owned ViiV Healthcare said its two-drug HIV regimen Dovato was as effective as Gilead Science Inc‘s GILD three-drug combo...

Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.